Mostrando 8 resultados de: 8
Filtros aplicados
Characterization and 3D model of a new proteinase inhibitor isolated from Stichodactyla helianthus
ArticleAbstract:Palabras claves:Autores:Besada-Pérez V., Betancourt L., Chávez M.d.l.A., Delfin J., Diaz J., Huerta V., Lima G., Lopez N., Padrón G., Vivian Morera CórdovaFuentes:scopusCharacterization of the primary structure of the recombinant human interleukin-2
ArticleAbstract:Palabras claves:Autores:Araña M.J., Besada-Pérez V., Castellanos L.R., López P., Mata H., Mateo de Acosta C., Richardson M., Vivian Morera CórdovaFuentes:scopusCharacterization of two experimental rodent models for evaluating novel drugs for rheumatoid arthritis
ArticleAbstract: Rodent models are widely used to evaluate molecular mechanisms of rheumatoid arthritis (RA) and potePalabras claves:Adjuvant arthritis, autoimmunity, Collagen-induced arthritis, RAT, Rheumatoid ArthritisAutores:Barberá A., Domínguez M.D.C., Hernández A., Lorenzo N., Merino N., Padrón G., Suaréz J., Vázquez A., Vivian Morera CórdovaFuentes:scopusDevelopment of new methods to study the amino terminal peptide of proteins and their applications in the biotechnological industry
ArticleAbstract:Palabras claves:Autores:Álvarez F., Besada-Pérez V., Betancourt L., De Cossio J.F., García Y., Gil J., González L.J., Moya G., Padrón G., Ramos Y., Sánchez A., Solano Y., Vivian Morera CórdovaFuentes:scopusEULAR 2004: Grand rheumatology meeting
Conference ObjectAbstract:Palabras claves:Autores:Vivian Morera CórdovaFuentes:scopusN-terminal peptide (1-92) of Sticholysin II generated by the cleavage with cyanogen bromide interacts with lipid bilayer but does not promote pore formation
ArticleAbstract: Sticholysin II (St II) is a pore-forming toxin produced by the sea anemone Stichodactyla helianthusPalabras claves:Actinoporin, CNBr-derived peptides, Pore-forming toxin, SticholysinAutores:Álvarez C., Casallanovo F., DallaSerra M., García Y., Lanio M.E., Lissi E.A., Martínez D., Menestrina G., Potrich C., Raida M., Schreier S., Vivian Morera CórdovaFuentes:scopusMolecular characterization of recombinant human interferon alpha-2b produced in Cuba
ArticleAbstract: The recombinant human interferon α 2b (IFN-γ(2b)) produced by Cuban technology is obtained from EschPalabras claves:IFN, Molecular characterization, Recombinant human interferon alfa 2bAutores:Beldarrain A., Besada-Pérez V., Betancourt L., Brito R., Curras T., Eugenio Hardy, Ferrero J., Gil M., González L.J., Herrera L., Huerta V., Martinez E., Moya G., Pujols V., Sanchez J.C., Santana-Milián H., Sosa R., Vivian Morera CórdovaFuentes:googlescopusProtective immune response against Neisseria meningitidis serogroup B after immunization with peptides mimicking a capsular polysaccharide epitope
ArticleAbstract:Palabras claves:Autores:Brown E., Caballero E., Carmenate T., Chinea G., Cobas K., Coizeau E., Cruz Y., Garay H.E., González S., Guillén-Nieto G.E., Martín A., Menéndez T., Noda J., Reyes O., Santiago Nelson Vispo, Soria Y., Vivian Morera Córdova, Yero D.Fuentes:scopus